A systematic review: the appraisal of the effects of metformin on lipoprotein modification and function

AIMS: Metformin is a commonly prescribed anti‐hyperglycaemic pharmacological agent, and it remains a staple in the management of type II diabetes. In addition to metformin's glucose lowering effects, research has indicated that metformin inhibits glycation‐mediated and oxidative modification of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kheniser, K. G., Kashyap, S. R., Kasumov, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381305/
https://www.ncbi.nlm.nih.gov/pubmed/30820329
http://dx.doi.org/10.1002/osp4.309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381305/
https://www.ncbi.nlm.nih.gov/pubmed/30820329
http://dx.doi.org/10.1002/osp4.309

Ejemplares similares